CA2234511A1 - Pyrazoles 1,3,5-trisubstitues pour le traitement des inflammations - Google Patents
Pyrazoles 1,3,5-trisubstitues pour le traitement des inflammations Download PDFInfo
- Publication number
- CA2234511A1 CA2234511A1 CA002234511A CA2234511A CA2234511A1 CA 2234511 A1 CA2234511 A1 CA 2234511A1 CA 002234511 A CA002234511 A CA 002234511A CA 2234511 A CA2234511 A CA 2234511A CA 2234511 A1 CA2234511 A1 CA 2234511A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- salt
- formula
- phenyl
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/16—Halogen atoms or nitro radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Composé de la formule (I). Dans cette formule, R?1¿ est hydroxyéthyle, 1-hydroxy-1-méthyléthyle, hydrogène, halogène, nitro ou cyano; R?2¿ est chloro, cyano, ou alkyle inférieur facultativement substitué par halogène, et R?3¿ est alkylthio inférieur, alkylsulfinyle inférieur, ou alkylsulfonyl inférieur, sous réserve que, lorsque R?1¿ est hydrogène, halogène, nitro ou cyano, R?2¿ est chloro. L'invention porte également sur un sel pharmaceutiquement acceptable de ce composé, sur des procédés conçus pour leur préparation et sur des compositions pharmaceutiquement acceptables.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9520584.5A GB9520584D0 (en) | 1995-10-09 | 1995-10-09 | Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same |
GB9520584.5 | 1995-10-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2234511A1 true CA2234511A1 (fr) | 1997-04-17 |
Family
ID=10782007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002234511A Abandoned CA2234511A1 (fr) | 1995-10-09 | 1996-10-08 | Pyrazoles 1,3,5-trisubstitues pour le traitement des inflammations |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0856000A1 (fr) |
JP (1) | JPH11513403A (fr) |
KR (1) | KR19990063989A (fr) |
CN (1) | CN1203589A (fr) |
AU (1) | AU7146196A (fr) |
CA (1) | CA2234511A1 (fr) |
GB (1) | GB9520584D0 (fr) |
WO (1) | WO1997013755A1 (fr) |
ZA (1) | ZA968286B (fr) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EE9900517A (et) * | 1997-04-18 | 2000-06-15 | G.D. Searle & Co. | Tsüklooksügenaas-2 inhibiitorite kasutamise meetod südameveresoonkonna haiguste ärahoidmiseks |
US5886191A (en) * | 1997-08-18 | 1999-03-23 | Dupont Pharmaceuticals Company | Amidinoindoles, amidinoazoles, and analogs thereof |
AUPO941497A0 (en) | 1997-09-24 | 1997-10-16 | Fujisawa Pharmaceutical Co., Ltd. | Novel compounds |
AUPP042397A0 (en) * | 1997-11-18 | 1997-12-11 | Fujisawa Pharmaceutical Co., Ltd. | 5-arylpyrazole compounds |
NZ333399A (en) | 1997-12-24 | 2000-05-26 | Sankyo Co | Cyclooxygenase-2 inhibitors (COX-2) for the prevention and treatment of tumors, cachexia and tumor-metastasis |
ES2137138B1 (es) * | 1998-05-29 | 2000-09-16 | Esteve Labor Dr | Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos. |
US6506747B1 (en) * | 1998-06-05 | 2003-01-14 | Boehringer Ingelheim Pharmaceuticals, Inc. | Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents |
US6294558B1 (en) | 1999-05-31 | 2001-09-25 | Pfizer Inc. | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
US6727238B2 (en) | 1998-06-11 | 2004-04-27 | Pfizer Inc. | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
WO2000018741A2 (fr) * | 1998-09-30 | 2000-04-06 | Fujisawa Pharmaceutical Co., Ltd. | Nouveaux composes |
ES2222919T3 (es) * | 1999-08-27 | 2005-02-16 | Abbott Laboratories | Compuestos sulfonilfenilpirazoles utiles como inhibidores de cox-2. |
TR200302047T4 (tr) | 1999-12-03 | 2004-01-21 | Pfizer Products Inc. | Anti-iltihabik / analjezik maddeler olarak heteroaril fenil pirazol bileşikleri. |
EP1104758B1 (fr) | 1999-12-03 | 2003-07-23 | Pfizer Products Inc. | Dérives acétylènes anti-inflammatoires et/ou analgésiques |
ATE234299T1 (de) | 1999-12-03 | 2003-03-15 | Pfizer Prod Inc | Sulfamoylheteroarylpyrazolverbindungen zur verwendung als analgetisches/entzündungshemmendes mittel |
DE60018792T2 (de) | 1999-12-03 | 2006-01-26 | Pfizer Products Inc., Groton | Heterocyclo-alkylsulfonylpyrazolderivate zur verwendung als anti-imflammatorische oder analgetische verbindungen |
DE60204823T2 (de) | 2001-07-05 | 2005-12-29 | Pfizer Products Inc., Groton | Heterocyclo-alkylsulfonyl Pyrazole als entzündungshemmende/analgetische Mittel |
AR038957A1 (es) | 2001-08-15 | 2005-02-02 | Pharmacia Corp | Terapia de combinacion para el tratamiento del cancer |
GT200200183A (es) | 2001-09-28 | 2003-05-23 | Procedimiento para preparar derivados de heterocicloalquilsulfonil pirazol | |
WO2003037336A1 (fr) | 2001-11-02 | 2003-05-08 | Pfizer Products Inc. | Derives de 1-(5-sulfonyl-pyridin-2-yl)-5-(methylidene-cycloalkylmethoxy)-1h-pyrazole-4-carbonitrile et autres composes utilises en tant qu'inhibiteurs de la cyclooxygenase dans le traitement de l'arthrite, de la neurodegeneration et du cancer du colon |
WO2004002420A2 (fr) | 2002-06-28 | 2004-01-08 | Nitromed, Inc. | Inhibiteurs a selectivite cyclooxygenase-2 nitrosiles et/ou nitroses contenant une oxime et/ou une hydrazone, compositions et methodes d'utilisation correspondantes |
CA2509605C (fr) | 2002-12-13 | 2010-10-05 | Warner-Lambert Company Llc | Ligand alpha-2-delta pour traiter des symptomes des voies urinaires inferieures |
ES2257929B1 (es) * | 2004-07-16 | 2007-05-01 | Laboratorios Del Dr. Esteve, S.A. | Derivados de pirazolina, procedimiento para su obtencion y utilizacion de los mismos como agentes terapeuticos. |
KR20090092307A (ko) | 2006-12-22 | 2009-08-31 | 레코르다티 아일랜드 리미티드 | 하요도 장애에 대한 α2δ 리간드 및 NSAIDs의 복합 치료 |
WO2014022382A2 (fr) * | 2012-07-30 | 2014-02-06 | The Ohio State University | Inhibiteurs de protéine kinase antibactérienne |
WO2022195579A1 (fr) | 2021-03-15 | 2022-09-22 | Saul Yedgar | Dipalmitoyl-phosphatidyl-éthanol-amine conjuguée à l'acide hyaluronique en combinaison avec des médicaments anti-inflammatoires non stéroïdiens (ains) pour traiter ou soulager des maladies inflammatoires |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PH27357A (en) * | 1989-09-22 | 1993-06-21 | Fujisawa Pharmaceutical Co | Pyrazole derivatives and pharmaceutical compositions comprising the same |
IL104311A (en) * | 1992-02-05 | 1997-07-13 | Fujisawa Pharmaceutical Co | Pyrazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
ATE212985T1 (de) * | 1993-11-30 | 2002-02-15 | Searle & Co | Tricyclische,substituierte pyrazolyl- benzolsulfonamide und ihre verwendung als cyclooxygenase ii inhibitoren |
US5466823A (en) * | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
US5434178A (en) * | 1993-11-30 | 1995-07-18 | G.D. Searle & Co. | 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation |
AU3815495A (en) * | 1994-11-08 | 1996-05-31 | Eisai Co. Ltd. | Pyrazole derivatives exhibiting anti-inflammatory and analgesic effects |
-
1995
- 1995-10-09 GB GBGB9520584.5A patent/GB9520584D0/en active Pending
-
1996
- 1996-10-02 ZA ZA968286A patent/ZA968286B/xx unknown
- 1996-10-08 WO PCT/JP1996/002919 patent/WO1997013755A1/fr not_active Application Discontinuation
- 1996-10-08 AU AU71461/96A patent/AU7146196A/en not_active Abandoned
- 1996-10-08 CA CA002234511A patent/CA2234511A1/fr not_active Abandoned
- 1996-10-08 JP JP9514909A patent/JPH11513403A/ja active Pending
- 1996-10-08 EP EP96932841A patent/EP0856000A1/fr not_active Withdrawn
- 1996-10-08 KR KR1019980702464A patent/KR19990063989A/ko not_active Application Discontinuation
- 1996-10-08 CN CN96198649A patent/CN1203589A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
ZA968286B (en) | 1997-05-13 |
JPH11513403A (ja) | 1999-11-16 |
AU7146196A (en) | 1997-04-30 |
WO1997013755A1 (fr) | 1997-04-17 |
CN1203589A (zh) | 1998-12-30 |
GB9520584D0 (en) | 1995-12-13 |
EP0856000A1 (fr) | 1998-08-05 |
KR19990063989A (ko) | 1999-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2234511A1 (fr) | Pyrazoles 1,3,5-trisubstitues pour le traitement des inflammations | |
US5134142A (en) | Pyrazole derivatives, and pharmaceutical composition comprising the same | |
EP0554829B1 (fr) | Dérivés du pyrazole à activité anti-inflammatoire, analgésique et antithrombotique | |
US4810719A (en) | Anti-inflammator 1,n-diarylpyrazol-3-amines | |
CA2443449C (fr) | Derives de pyrazole pour le traitement de vih | |
US5550147A (en) | Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same | |
CA2087260A1 (fr) | Alkylsulfonylpyrazoles aryliques substituees comme herbicide | |
Tsuji et al. | Studies on anti-inflammatory agents. IV. Synthesis and pharmacological properties of 1, 5-diarylpyrazoles and related derivatives | |
FI79103C (fi) | Foerfarande foer framstaellning av terapeutiskt aktiva 1,4-dihydropyridinderivat. | |
US5128343A (en) | Derivatives of pyrimidinyl-piperazinyl-alkyl azoles with anxiolytic and/or tranquilizing activity | |
HU217907B (hu) | Kinolin- vagy kinazolinszármazékok, eljárás a vegyületek előállítására és a vegyületeket tartalmazó gyógyászati készítmények | |
EP1442026B1 (fr) | Derives de triazole utiles comme inhibiteurs de la cyclooxygenase (cox) | |
EP0510036B1 (fr) | 4,5-diphenyl-imidazoles substitues en position 2 | |
CA2047880A1 (fr) | Derives de benzimidazole, leur preparation, et leur application en tant que medicaments | |
US6316485B1 (en) | 1,5-diphenylpyrazole derivatives | |
WO1999025695A1 (fr) | Composes 5-arylpyrazole | |
Drutkowski et al. | Derivatives of arylhydrazonic acids. Part 2: A facile approach to novel 4, 5-dihydro-1H-1, 2, 4-triazoles via cyclization of amidrazones | |
HU201015B (en) | Process for producing pyridine derivatives | |
AU2004200420A1 (en) | Inhibitor of cyclooxygenase | |
WO2000018741A2 (fr) | Nouveaux composes | |
US4657906A (en) | Heterocyclic compounds having inotropic activity | |
JPH10291982A (ja) | 新規複素環化合物 | |
AU750356B2 (en) | 1,5-diphenylpyrazole derivatives | |
AU2005288671A1 (en) | Process for preparing bicyclic pyrazolyl compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |